Skip to main content
TIBET AIM PHARM. INC. logo

TIBET AIM PHARM. INC. — Investor Relations & Filings

Ticker · 002826 ISIN · CNE100002C39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,084 across all filing types
Latest filing 2023-04-26 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002826

About TIBET AIM PHARM. INC.

https://www.emyy.cn

Tibet Aim Pharm. Inc. is a pharmaceutical enterprise focused on the research, development, production, and distribution of medicinal products. The company integrates traditional Tibetan medicine with modern pharmaceutical manufacturing processes to develop a diverse portfolio of treatments. Its core product range typically includes cardiovascular medications, digestive system therapies, and specialized herbal formulations derived from high-altitude botanical sources. Tibet Aim Pharm. Inc. emphasizes the modernization of traditional formulas through rigorous clinical testing and standardized production techniques. The company serves healthcare providers and patients by providing therapeutic solutions that bridge ancient medical knowledge with contemporary scientific standards.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2022 年度内部控制自我评价报告' which translates to '2022 Annual Internal Control Self-Evaluation Report'. It is a detailed report on the company's internal control evaluation for the year ending December 31, 2022. The content includes internal control scope, evaluation conclusions, control activities, risk assessments, and defect recognition standards. It is a comprehensive internal control report rather than a general annual report or audit report. The document does not appear to be an announcement or a brief summary but a full report with substantive content. This type of document fits best under the category of Audit Report / Information (AR), as it is a standalone report on internal control evaluation and related audit-like information, not the full annual report (10-K) or other categories. FY 2022
2023-04-26 Chinese
关于高级管理人员辞职的公告
Board/Management Information Classification · 100% confidence The document is a short announcement regarding the resignation of a senior management member (the vice general manager) of the company. It includes details about the resignation, effective date, and confirms that the resignation will not affect normal operations. There is no financial data, no mention of reports or filings, and the content clearly relates to management changes. The document length is only 408 characters, indicating it is a brief announcement rather than a detailed report. Therefore, the appropriate classification is 'Board/Management Information' (MANG).
2023-04-26 Chinese
2022年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2022 年年度报告全文" which translates to "2022 Annual Report Full Text" for 西藏易明西雅医药科技股份有限公司. It contains detailed sections typical of an annual report such as company overview, financial data, management discussion and analysis, governance, social responsibility, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes signed financial statements and an audit report, confirming it is the official comprehensive yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2022
2023-04-26 Chinese
关于回购注销部分限制性股票减资暨通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement by a company regarding the repurchase and cancellation of restricted shares, which leads to a reduction in registered capital. It includes details about the board meeting resolutions, the number of shares repurchased, the repurchase price, and the legal notification to creditors about the capital reduction. The document references previous announcements and provides instructions for creditors to claim debts or request guarantees. The content is focused on a capital change event involving share repurchase and capital reduction, not a financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication announcement or a certification, so SHA is appropriate with high confidence.
2023-04-26 Chinese
独立董事对担保等事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on various matters discussed at the company's third board of directors' twelfth meeting. It covers topics such as related party transactions, internal control self-assessment, profit distribution proposals, reappointment of the auditing firm, cash management, stock repurchase and cancellation of restricted stock, adjustment of repurchase price, and authorization for simplified issuance of shares to specific targets. The document references the 2022 fiscal year and includes opinions on proposals to be submitted to the 2022 annual shareholders' meeting. It is not a full annual report or audit report but rather an independent opinion related to board meeting matters and proposals for shareholder approval. This fits best under Board/Management Information (MANG), which includes announcements of changes or opinions related to board or management decisions.
2023-04-26 Chinese
年度股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2022 Annual General Meeting (AGM) of the company 西藏易明西雅医药科技股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be voted on, and instructions for shareholders. It also contains an authorization proxy form for shareholders to delegate voting rights. The document does not contain actual financial statements or results but is focused on informing shareholders about the AGM logistics and agenda. Therefore, it fits the category of AGM Information (AGM-R). The document length is about 4817 characters, which is consistent with a detailed AGM notice rather than a full annual report or other filings.
2023-04-26 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.